Medicine and Dentistry
Patient
100%
Diabetes Mellitus
100%
Surveillance
100%
Organ
100%
Cyclosporine
100%
Transplantation
100%
Interim Analysis
100%
Development
18%
Incidence
18%
Diabetes
18%
Death
18%
Acute Graft Rejection
18%
Survival Rate
9%
Infection
9%
Age
9%
Follow up
9%
Evaluation Study
9%
Liver
9%
Combination Therapy
9%
Adverse Event
9%
Overall Survival
9%
Association
9%
Respiratory Failure
9%
Complication
9%
Cancer
9%
Biopsy
9%
Body Mass Index
9%
High-Density Lipoprotein
9%
Triacylglycerol
9%
Corticosteroid
9%
Immunosuppressive Drug
9%
Allograft
9%
Immunosuppressive Treatment
9%
Heart
9%
Blood Pressure
9%
Graft Survival
9%
Hepatitis C Virus
9%
Gender
9%
Meningitis
9%
Graft Failure
9%
Calcineurin Inhibitor
9%
Cytomegalovirus
9%
Mycophenolate Mofetil
9%
Mycophenolic Acid
9%
Heart Graft
9%
Immunology and Microbiology
Transplantation
100%
Ciclosporin
100%
Organ
100%
Development
33%
Incidence
33%
Time
33%
Heart
33%
Acute Graft Rejection
33%
Mycophenolic Acid
33%
Age
16%
Association
16%
Survival
16%
Overall Survival
16%
Survival Rate
16%
Liver
16%
Allotransplantation
16%
Immunosuppressive Therapy
16%
Density
16%
Solid
16%
Hepatitis C Virus
16%
Meningitis
16%
Gender
16%
Body Mass
16%
Blood Pressure
16%
Cytomegalovirus
16%
Basiliximab
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Ciclosporin
100%
Postmarketing Surveillance
100%
Death
15%
Incidence
15%
Immunosuppressive Agent
15%
Acute Graft Rejection
15%
Mycophenolate Mofetil
15%
Corticosteroid
7%
Infection
7%
Triacylglycerol
7%
Adverse Event
7%
Survival
7%
Overall Survival
7%
Survival Rate
7%
High Density Lipoprotein
7%
Complication
7%
Calcineurin Inhibitor
7%
Hepatitis C Virus
7%
Respiratory Failure
7%
Meningitis
7%
Graft Failure
7%
Cytomegalovirus
7%
Basiliximab
7%